CTIM-14. COMPREHENSIVE BIOMARKER ANALYSIS OF RESPONDERS AND NON-RESPONDERS IN A PHASE IIA TRIAL OF A CMV VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901)
Wen, Patrick Y, Reardon, David A, Forst, Deborah, Lee, Eudocia, Daoud, Teresa, Berthoud, Tamara, Soare, Catalina, Diaz-Mitoma, Francisco, Anderson, David E, Lassman, Andrew, Iwamoto, Fabio
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Get full text
Journal Article
Evaluation of tumor responses and overall survival in patients with recurrent glioblastoma (GBM) from a phase IIa trial of a CMV vaccine immunotherapeutic candidate (VBI-1901)
Wen, Patrick Y., Reardon, David A., Forst, Deborah Anne, Lee, Eudocia Quant, Haas, Brittany, Daoud, Teresa, Berthoud, Tamara, Diaz-Mitoma, Francisco, Anderson, David E, Lassman, Andrew B., Iwamoto, Fabio Massaiti
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article